Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001335341 | SCV001528471 | uncertain significance | 46,XY sex reversal 6 | 2018-11-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001335341 | SCV002246307 | benign | 46,XY sex reversal 6 | 2022-08-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547339 | SCV003701326 | uncertain significance | Inborn genetic diseases | 2022-04-12 | criteria provided, single submitter | clinical testing | The c.44C>G (p.P15R) alteration is located in exon 1 (coding exon 1) of the MAP3K1 gene. This alteration results from a C to G substitution at nucleotide position 44, causing the proline (P) at amino acid position 15 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |